---
$id: https://graph.org.ai/products/commodity/51141554
$type: Product
source: UNSPSC
code: "51141554"
title: "Dinazafone"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dinazafone

**UNSPSC Code**: 51141554
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 411OG24QOU. European Medicines Agency schedules Dinazafone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07191MIG. Dinazafone generally arises in the molecular formula C20H21CLN2O2. The term DINAZAFONE is an International Non-Proprietary Name or INN. DINAZAFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dinazafone under HS 29242995 and SITC 51479. As of Q4 2014, DINAZAFONE remains the US FDA Preferred Term for this commodity. Dinazafone bears US NLM identifiers UMLS ID C1880337 and NCI Concept Code C65411. SMILES: CLC1CC(C(N(C(=O)CNCC(=C)C)C)CC1)C(=O)C1CCCCC1.

